Type | Public | |
Founded | 2001 | |
HQ | Cambridge, MA, US | Map |
Website | aveooncology.com | |
Employee Ratings | More |
USD | |
---|---|
Revenue (Q2, 2020) | 749.0k |
Net income (Q2, 2020) | (7.3m) |
EBIT (Q2, 2020) | (7.4m) |
Market capitalization (15-Jan-2021) | 235.7m |
Closing stock price (15-Jan-2021) | 8.2 |
Cash (30-Jun-2020) | 45.7m |
EV | 202.0m |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 26.6m | 3.6m | 860.0k | 1.9m | 1.0m | 323.0k | 324.0k | 323.0k | 15.3m | 1.8m | 873.0k | 134.0k | 134.0k | 15.2m | 1.2m | 193.0k | 992.0k | 2.5m | 351.0k | 4.6m | 1.0m | 433.0k | 2.5m | 1.6m | 703.0k | 25.7m | 784.0k | 749.0k |
General and administrative expense | 6.4m | 6.6m | 9.0m | 9.2m | 9.3m | 12.4m | 7.3m | 4.4m | 5.6m | 4.8m | 5.1m | 3.3m | 2.9m | 2.2m | 2.5m | 1.7m | 2.1m | 2.3m | 2.3m | 2.1m | 2.6m | 2.8m | 2.7m | 2.5m | 3.0m | 2.9m | 3.7m | 3.7m |
R&D expense | 25.1m | 20.1m | 24.8m | 21.5m | 21.1m | 21.0m | 16.2m | 19.4m | 11.8m | 9.3m | 8.5m | 2.7m | 1.8m | 4.5m | 6.0m | 5.6m | 4.4m | 8.0m | 6.9m | 4.7m | 5.4m | 4.9m | 5.2m | 6.9m | 2.6m | 4.0m | 7.8m | 4.4m |
Operating expense total | 31.4m | 26.7m | 33.8m | 30.6m | 30.4m | 33.4m | 23.5m | 23.9m | 17.3m | 14.1m | 13.6m | 6.0m | 4.7m | 6.7m | 8.4m | 7.3m | 6.6m | 10.3m | 9.2m | 6.8m | 8.0m | 7.7m | 7.9m | 9.3m | 5.6m | 6.9m | 11.5m | 8.2m |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 81.0m | 45.9m | 73.1m | 85.8m | 114.1m | 85.9m | 33.8m | 50.4m | 46.3m | 43.4m | 60.0m | 34.5m | 26.8m | 34.7m | 18.1m | 25.3m | 12.4m | 33.4m | 30.9m | 16.4m | 16.2m | 18.1m | 20.4m | 23.5m | 40.2m | 57.7m | 23.5m | 45.7m |
Accounts Receivable | 28.8m | 9.7m | 9.5m | 9.2m | 9.3m | 9.2m | 7.9m | 8.9m | 1.3m | 1.2m | 1.7m | 947.0k | 2.3m | 2.3m | 1.7m | 1.3m | 990.0k | 676.0k | 445.0k | 2.4m | 600.0k | 973.0k | 344.0k | 2.6m | 611.0k | 1.1m | 2.8m | 1.2m |
Prepaid Expenses | 9.3m | 5.6m | 3.5m | 5.2m | 7.8m | 9.7m | 9.2m | 7.2m | 2.0m | 3.7m | 3.3m | 1.4m | 1.4m | 1.4m | 1.1m | |||||||||||||
Current Assets | 302.4m | 275.1m | 237.3m | 230.3m | 206.8m | 210.6m | 173.3m | 146.5m | 105.6m | 85.4m | 71.5m | 44.4m | 33.4m | 43.8m | 30.7m | 42.3m | 34.0m | 35.9m | 42.1m | 41.5m | 43.6m | 20.0m | 21.4m | 26.3m | 41.7m | 59.8m | 37.1m | 74.2m |
USD | FY, 2011 | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 |
---|---|---|---|---|---|---|---|---|---|
Net Income | 30.6m | (114.4m) | (107.0m) | (52.7m) | (15.0m) | (26.9m) | (65.0m) | (5.3m) | 9.4m |
Depreciation and Amortization | 1.7m | 2.5m | 3.8m | 6.2m | 9.6m | 30.0k | |||
Accounts Payable | (343.0k) | 1.7m | (6.4m) | (993.0k) | (1.8m) | 760.0k | 250.0k | 1.1m | (2.0m) |
Cash From Operating Activities | 26.5m | (105.7m) | (84.4m) | (54.2m) | (18.2m) | (31.1m) | (19.2m) | (25.0m) | (2.9m) |
USD | Q2, 2011 | Q3, 2011 | Q1, 2012 | Q2, 2012 | Q3, 2012 | Q1, 2013 | Q2, 2013 | Q3, 2013 | Q1, 2014 | Q2, 2014 | Q3, 2014 | Q1, 2015 | Q2, 2015 | Q3, 2015 | Q1, 2016 | Q2, 2016 | Q3, 2016 | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | 79.6m | 55.8m | (33.2m) | (62.8m) | (92.9m) | (34.1m) | (66.0m) | (90.3m) | (6.4m) | (24.4m) | (38.8m) | (10.9m) | (16.3m) | (8.4m) | (7.7m) | (16.3m) | (21.3m) | (8.8m) | (42.1m) | (68.5m) | (9.0m) | (5.0m) | (27.1m) | 555.0k | (2.6m) | 13.8m | (8.4m) | (15.7m) |
Depreciation and Amortization | 765.0k | 1.2m | 546.0k | 1.1m | 1.8m | 1.9m | 2.8m | 838.0k | 1.7m | 2.8m | 4.5m | 9.5m | 9.6m | 5.0k | 7.0k | 7.0k | 4.0k | |||||||||||
Accounts Payable | 3.7m | 431.0k | (1.3m) | (4.6m) | 1.4m | (3.4m) | (4.5m) | (1.6m) | (738.0k) | (2.6m) | (626.0k) | (1.7m) | (3.0m) | (1.1m) | 656.0k | (246.0k) | 1.1m | 1.2m | (245.0k) | 944.0k | 386.0k | 547.0k | (1.4m) | (1.5m) | (1.3m) | 1.5m | 319.0k | |
Cash From Operating Activities | 45.5m | 46.4m | (30.6m) | (58.3m) | (82.4m) | (53.5m) | (75.7m) | (19.8m) | (35.2m) | (43.2m) | (15.8m) | (27.2m) | (18.2m) | (10.3m) | (14.9m) | (23.6m) | (5.4m) | (12.4m) | (15.4m) | (6.5m) | (15.6m) | (18.4m) | (8.5m) | (14.5m) | 4.5m | (11.7m) | (19.2m) |
USD | Q2, 2011 |
---|---|
Financial Leverage | 1.3 x |
AVEO Pharmaceuticals has 904 Twitter Followers. The number of followers has increased 0.4% month over month and increased 0.8% quarter over quarter
190
Tweets
208
Following
904
Followers
4
Tweets last 30 days
0.3
Avg. likes per Tweet
25%
Tweets with engagement
When was AVEO Pharmaceuticals founded?
AVEO Pharmaceuticals was founded in 2001.
Who are AVEO Pharmaceuticals key executives?
AVEO Pharmaceuticals's key executives are Erick Lucera, Kenneth M. Bate and Keith Ehrlich.
How many employees does AVEO Pharmaceuticals have?
AVEO Pharmaceuticals has 19 employees.
What is AVEO Pharmaceuticals revenue?
Latest AVEO Pharmaceuticals annual revenue is $28.8 m.
What is AVEO Pharmaceuticals revenue per employee?
Latest AVEO Pharmaceuticals revenue per employee is $1.5 m.
Who are AVEO Pharmaceuticals competitors?
Competitors of AVEO Pharmaceuticals include Mirati Therapeutics, Calithera Biosciences and GlycoMimetics.
Where is AVEO Pharmaceuticals headquarters?
AVEO Pharmaceuticals headquarters is located at One Broadway, 1 Broadway 14th Floor, Cambridge.
Where are AVEO Pharmaceuticals offices?
AVEO Pharmaceuticals has offices in Cambridge and Boston.
How many offices does AVEO Pharmaceuticals have?
AVEO Pharmaceuticals has 2 offices.
Receive alerts for 300+ data fields across thousands of companies